Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Microbiology Resource Announcements
|
September 25, 2023
A high-throughput structural system biology approach to increase structure representation of proteins from <i>Clostridioides difficile</i>
Monica Rosas-Lemus, Supratim Dey, George Minasov, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 5, 2014
Salvage of failed protein targets by reductive alkylation
Kemin Tan, Youngchang Kim, Catherine Hatzos-Skintges, et al.
The Journal of Biological Chemistry
|
June 14, 2015
Functional Diversity of Haloacid Dehalogenase Superfamily Phosphatases from Saccharomyces cerevisiae: BIOCHEMICAL, STRUCTURAL, AND EVOLUTIONARY INSIGHTS
Ekaterina Kuznetsova, Boguslaw Nocek, Greg Brown, et al.
Immunological Reviews
|
January 2, 2025
Biophysical and Structural Features of αβT-Cell Receptor Mechanosensing: A Paradigmatic Shift in Understanding T-Cell Activation
Robert J Mallis, Kristine N Brazin, Jonathan S Duke-Cohan, et al.
Nature Communications
|
May 22, 2023
Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide
Xiaolong Li, Nishant Kumar Singh, David R Collins, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Atomistic TCR-ligand interactions instruct memory T-cell differentiation
Aoi Akitsu, Kemin Tan, Robert J Mallis, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detection
Koji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Science (New York, N.Y.)
|
July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Nature Methods
|
November 6, 2007
In situ proteolysis for protein crystallization and structure determination
Aiping Dong, Xiaohui Xu, Aled M Edwards, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Microbiology Resource Announcements
|
September 25, 2023
A high-throughput structural system biology approach to increase structure representation of proteins from <i>Clostridioides difficile</i>
Monica Rosas-Lemus, Supratim Dey, George Minasov, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 5, 2014
Salvage of failed protein targets by reductive alkylation
Kemin Tan, Youngchang Kim, Catherine Hatzos-Skintges, et al.
The Journal of Biological Chemistry
|
June 14, 2015
Functional Diversity of Haloacid Dehalogenase Superfamily Phosphatases from Saccharomyces cerevisiae: BIOCHEMICAL, STRUCTURAL, AND EVOLUTIONARY INSIGHTS
Ekaterina Kuznetsova, Boguslaw Nocek, Greg Brown, et al.
Immunological Reviews
|
January 2, 2025
Biophysical and Structural Features of αβT-Cell Receptor Mechanosensing: A Paradigmatic Shift in Understanding T-Cell Activation
Robert J Mallis, Kristine N Brazin, Jonathan S Duke-Cohan, et al.
Nature Communications
|
May 22, 2023
Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide
Xiaolong Li, Nishant Kumar Singh, David R Collins, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Atomistic TCR-ligand interactions instruct memory T-cell differentiation
Aoi Akitsu, Kemin Tan, Robert J Mallis, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Cancers modulate p53 truncal neoantigen display to evade T cell detection
Koji Haratani, Bruce Reinhold, Jonathan S Duke-Cohan, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Science (New York, N.Y.)
|
July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Nature Methods
|
November 6, 2007
In situ proteolysis for protein crystallization and structure determination
Aiping Dong, Xiaohui Xu, Aled M Edwards, et al.
Page
of 7